1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids for Chronic Inflammatory Conditions
|2||Not yet recruiting||
Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation
Treatment of Low Bone Density in Cystic Fibrosis.
† Indicates status has not been verified in more than two years